Veru Healthcare Company
Veru is an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer and breast cancers. Our strategy is primarily to focus on the clinical development and commercialization of oncology drugs for the management of two of the most prevalent cancers globally – prostate cancer and breast cancer.
Technology:
Medical Devices
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Employees Number:
251-500
Funding Status:
IPO
Register and Claim Ownership